MetaCap

Rapid Micro Biosystems (RPID) vs Xtant Medical (XTNT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Xtant Medical (XTNT) has outperformed Rapid Micro Biosystems (RPID) over the past year, losing 52.8% versus a loss of 75.4%. Over five years, XTNT leads with a -71.1% price change compared with -94.9% for RPID. Xtant Medical is the larger company by market cap ($45.0 million vs $43.2 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

RPID-75.38%XTNT-52.79%
+41%-20%-81%
Oct 8, 20251 yearOct 8, 2026
RPID-95.33%XTNT-71.84%
+24%-39%-102%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

RPID versus XTNT key metrics
MetricRPIDXTNT
Share price$0.8617$0.321
Market cap$43.22M$45.03M
1-day change-4.01%-0.16%
YTD return-70.29%-58.85%
1-year return-75.38%-52.79%
5-year return-94.88%-71.08%
EPS (TTM)$-1.11$-0.08
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$4.94$0.95
52-week low$0.826$0.27
Distance from 52-week high-82.56%-66.21%
Analyst consensusstrong_buynone
Avg. price target upside+567.29%+220.87%
Average volume271.93K1.69M
Shares outstanding45.66M140.29M
Employees171151
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Devices

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • XTNT has outperformed RPID by 22.6 percentage points over the past year.

About Rapid Micro Biosystems

RPID stock →

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

Healthcare · Medical Devices · 171 employees

About Xtant Medical

XTNT stock →

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.

Healthcare · Medical Devices · 151 employees

RPID vs XTNT FAQ

Which is bigger, Rapid Micro Biosystems or Xtant Medical?

Xtant Medical (XTNT) is larger, with a market capitalization of $45.03M compared with $43.22M for Rapid Micro Biosystems (RPID).

Which stock has performed better over the past year, RPID or XTNT?

XTNT returned -52.79% over the past 12 months, compared with -75.38% for RPID (price return, excluding dividends). Past performance does not predict future results.

Are Rapid Micro Biosystems and Xtant Medical in the same industry?

Yes. Both are classified in the Medical Devices industry within the Healthcare sector.

More comparisons